1st May 2025, Kathmandu
Om Megashree Pharmaceuticals is set to begin share trading on the secondary market from Sunday, May 4, 2025 (Baisakh 21, 2082). NEPSE has completed the listing process and issued the opening range for the company’s stock.
Om Megashree IPO Listing Nepal
IPO Shares Officially Listed
On Wednesday, Nepal Stock Exchange (NEPSE) listed 6 million shares of Om Megashree Pharmaceuticals. These include 4.2 million promoter shares and 1.8 million public shares.
NEPSE registered the shares under the trading symbol ‘OMPL’.
Why Trading Starts on Sunday
Usually, shares begin trading a day after listing. However, Thursday was a public holiday, and the stock market remained closed on Friday. Due to this, trading will start on Sunday instead.
Opening Price Range Issued
NEPSE set an opening range between NPR 90.17 and NPR 270.51 per share. The company’s stock will first trade in the special pre-open session.
If a deal occurs within this range, it will move into normal trading from the same day.
This price range reflects investor demand, company performance, and market guidelines.
IPO Process Completed in March
Om Megashree opened its Initial Public Offering (IPO) for public subscription from 11 March to 16 March. The IPO allotment took place on 25 March at Prabhu Capital, the issue manager.
Thousands of general investors participated in the offering.
Investor Expectations High
Investors are closely watching the company’s debut. The pharmaceutical sector in Nepal has gained momentum, especially after the pandemic.
Om Megashree’s strong public response during the IPO indicates good demand in the secondary market as well.
Many believe the stock will attract long-term investors due to the company’s sector and market potential.
Broader Impact on Capital Market
This listing contributes to sectoral diversity in NEPSE. Currently, very few pharmaceutical companies are listed.
Om Megashree’s entry may encourage more firms in the health and medicine sector to approach the stock market.
It also supports Nepal’s growing pharmaceutical industry and promotes capital mobilization.
Company’s Future Plans
Om Megashree aims to use the raised capital for expanding manufacturing, investing in R&D, and strengthening its distribution.
The company plans to scale its reach across the country.
Management expects sustainable growth and is working to maintain investor confidence.
In Summary
Om Megashree Pharmaceuticals is starting a new chapter as a listed company. NEPSE has approved its entry, and the shares will start trading on Sunday.
With a defined opening range and positive market sentiment, the company is expected to perform well in its debut. This move also signals a stronger involvement of the pharmaceutical sector in Nepal’s stock market.
For more: Om Megashree IPO Listing Nepal